New Sanofi/Alphabet partnership names CEO
pharmafile | September 12, 2016 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Alphabet, Sanofi, Verily, appointment, google
As part of the news that French drugmaker Sanofi and Google parent Alphabet’s life sciences firm Verily are to join forces to form diabetes-focused venture Onduo, the union has named its CEO.
Dr Joshua Riff has been appointed to the position and will lead the Cambridge-based company in its mission to improve quality of life for diabetes sufferers by developing solutions that combine devices, software, medicine, and professional care.
“My experience as a physician and in leading consumer health initiatives has shown me the daily burden of living with diabetes,” said Dr Riff. “From monitoring food intake to testing glucose levels to actively seeking medical care, the challenges both on the physical and mental well-being of a person living with diabetes are incredibly difficult. We want to develop solutions that allow people living with diabetes to focus on the things they love and enjoy in life by providing tools to make dealing with their diabetes less burdensome.”
Dr Riff previously served as senior vice president of prevention and wellbeing at Optum, the health services company of UnitedHealth Group.
Related Content

Sanofi and Regeneron’s Dupixent receives CHMP recommendation for chronic spontaneous urticaria
Sanofi and Regeneron have received a positive opinion from the European Medicines Agency’s (EMA) Committee …

Sanofi’s treatment granted orphan designation for rare chronic inflammatory condition
The European Medicines Agency has granted orphan designation to Sanofi’s investigational Bruton’s tyrosine kinase (BTK) …

Sanofi completes acquisition of Vigil Neuroscience to early neurology pipeline
Sanofi has announced that it has finalised its acquisition of Vigil Neuroscience, a US-based biotechnology …






